CH5.L vs. ANXU.L

Last updated Jun 5, 2026

CH5.L (Amundi ETF MSCI Europe Healthcare UCITS ETF) and ANXU.L (Amundi Nasdaq-100 UCITS USD) are both exchange-traded funds - CH5.L is a Health & Biotech Equities fund tracking the MSCI World/Health Care NR USD, while ANXU.L is a Nasdaq-100 fund tracking the Russell 1000 Growth TR USD. Both are passively managed. Over the past 10 years, CH5.L returned -3.17%/yr vs 22.69%/yr for ANXU.L. At a 0.35 correlation, their price movements are largely independent. CH5.L charges 0.25%/yr vs 0.13%/yr for ANXU.L.

Performance

CH5.L vs. ANXU.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in Amundi ETF MSCI Europe Healthcare UCITS ETF (CH5.L) and Amundi Nasdaq-100 UCITS USD (ANXU.L). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

CH5.L is traded in GBp, while ANXU.L is traded in USD. To make them comparable, the ANXU.L values have been converted to GBp using the latest available exchange rates.

Returns By Period

In the year-to-date period, CH5.L achieves a -3.01% return, which is significantly lower than ANXU.L's 20.95% return. Over the past 10 years, CH5.L has underperformed ANXU.L with an annualized return of -3.17%, while ANXU.L has yielded a comparatively higher 22.69% annualized return.

CH5.L

• 1D: 3.21%
• 1M: 1.61%
• YTD: -3.01%
• 6M: -1.61%
• 1Y: 8.05%
• 3Y*: -26.49%
• 5Y*: -13.43%
• 10Y*: -3.17%

ANXU.L

• 1D: 0.00%
• 1M: 10.24%
• YTD: 20.95%
• 6M: 19.24%
• 1Y: 42.83%
• 3Y*: 25.22%
• 5Y*: 19.21%
• 10Y*: 22.69%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CH5.L vs. ANXU.L - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CH5.L Amundi ETF MSCI Europe Healthcare UCITS ETF	-3.01%	11.85%	-63.23%	5.38%	1.64%	17.03%	3.58%	24.30%	0.41%	6.87%
ANXU.L Amundi Nasdaq-100 UCITS USD	20.15%	11.32%	28.95%	48.68%	-25.30%	28.68%	41.33%	36.74%	4.00%	20.61%

Correlation

The correlation between CH5.L and ANXU.L is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.07
Correlation (3Y) Calculated over the trailing 3-year period	0.18
Correlation (5Y) Calculated over the trailing 5-year period	0.25
Correlation (10Y) Calculated over the trailing 10-year period	0.36
Correlation (All Time) Calculated using the full available price history since Jan 15, 2013	0.35

Over the past year, the correlation between CH5.L and ANXU.L has dropped to 0.07 - well below their long-term average of 0.35, suggesting their price drivers have been diverging.

CH5.L vs. ANXU.L - Sectors Allocation Comparison

Sectors	CH5.L	ANXU.L
Industrials	37.9%	3.1%
Healthcare	28.0%	4.2%
Financial Services	18.5%	0.2%
Technology	15.7%	53.7%
Consumer Cyclical	6.6%	12.2%
Basic Materials	3.3%	1.1%
Consumer Defensive	1.8%	7.7%
Energy	1.5%	0.6%
Utilities	0.6%	1.4%
Real Estate	0.5%	0.1%
Communication Services	0.0%	15.8%

Return for Risk

CH5.L vs. ANXU.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CH5.L

CH5.L Risk / Return Rank: 17
CH5.L Sharpe Ratio Rank: 17
CH5.L Sortino Ratio Rank: 17
CH5.L Omega Ratio Rank: 17
CH5.L Calmar Ratio Rank: 17
CH5.L Martin Ratio Rank: 16

ANXU.L

ANXU.L Risk / Return Rank: 76
ANXU.L Sharpe Ratio Rank: 79
ANXU.L Sortino Ratio Rank: 79
ANXU.L Omega Ratio Rank: 75
ANXU.L Calmar Ratio Rank: 74
ANXU.L Martin Ratio Rank: 71

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CH5.L vs. ANXU.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amundi ETF MSCI Europe Healthcare UCITS ETF (CH5.L) and Amundi Nasdaq-100 UCITS USD (ANXU.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CH5.L	ANXU.L	Difference
Sharpe ratio: Return per unit of total volatility	0.49	2.68	-2.19
Sortino ratio: Return per unit of downside risk	0.84	3.56	-2.72
Omega ratio: Gain probability vs. loss probability	1.10	1.47	-0.38
Calmar ratio: Return relative to maximum drawdown	0.60	3.83	-3.24
Martin ratio: Return relative to average drawdown	1.43	10.84	-9.41
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CH5.L vs. ANXU.L - Sharpe Ratio Comparison

The current CH5.L Sharpe Ratio is 0.49, which is lower than the ANXU.L Sharpe Ratio of 2.68. The chart below compares the historical Sharpe Ratios of CH5.L and ANXU.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CH5.L	ANXU.L	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.49	2.68	-2.19
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.42	0.96	-1.39
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.13	1.23	-1.35
Sharpe Ratio (All Time) Calculated using the full available price history	0.02	1.30	-1.27

Drawdowns

CH5.L vs. ANXU.L - Drawdown Comparison

The maximum CH5.L drawdown since its inception was -70.04%, which is greater than ANXU.L's maximum drawdown of -27.52%. Use the drawdown chart below to compare losses from any high point for CH5.L and ANXU.L.

Drawdown Indicators

	CH5.L	ANXU.L	Difference
Max Drawdown Largest peak-to-trough decline	-70.04%	-27.52%	-42.52%
Max Drawdown (1Y) Largest decline over 1 year	-13.44%	-11.12%	-2.32%
Max Drawdown (3Y) Largest decline over 3 years	-70.04%	-24.28%	-45.76%
Max Drawdown (5Y) Largest decline over 5 years	-70.04%	-27.52%	-42.52%
Max Drawdown (10Y) Largest decline over 10 years	-70.04%	-27.52%	-42.52%
Current Drawdown Current decline from peak	-64.16%	0.00%	-64.16%
Average Drawdown Average peak-to-trough decline	-14.80%	-4.99%	-9.81%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.61%	3.94%	+1.67%

Volatility

CH5.L vs. ANXU.L - Volatility Comparison

Amundi ETF MSCI Europe Healthcare UCITS ETF (CH5.L) has a higher volatility of 5.66% compared to Amundi Nasdaq-100 UCITS USD (ANXU.L) at 5.02%. This indicates that CH5.L's price experiences larger fluctuations and is considered to be riskier than ANXU.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CH5.L	ANXU.L	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.66%	5.02%	+0.64%
Volatility (6M) Calculated over the trailing 6-month period	11.79%	11.74%	+0.05%
Volatility (1Y) Calculated over the trailing 1-year period	16.28%	15.89%	+0.39%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	31.85%	20.08%	+11.77%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	25.28%	21.15%	+4.13%

CH5.L vs. ANXU.L - Expense Ratio Comparison

CH5.L has a 0.25% expense ratio, which is higher than ANXU.L's 0.13% expense ratio. However, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.

Dividends

CH5.L vs. ANXU.L - Dividend Comparison

Neither CH5.L nor ANXU.L has paid dividends to shareholders.

Tickers have no history of dividend payments

Frequently Asked Questions

Can I hold both CH5.L and ANXU.L in my portfolio?

CH5.L and ANXU.L have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, CH5.L or ANXU.L?

On fees, ANXU.L is cheaper at 0.13% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CH5.L or ANXU.L?

ANXU.L is cheaper with a 0.13% expense ratio, compared with 0.25% for CH5.L.

What is the main difference between CH5.L and ANXU.L?

CH5.L is categorized as Health & Biotech Equities, while ANXU.L is Nasdaq-100. CH5.L tracks MSCI World/Health Care NR USD, while ANXU.L tracks Russell 1000 Growth TR USD. Their fees differ too: 0.25% for CH5.L and 0.13% for ANXU.L.